Autophagy genes variants and paediatric Crohn's disease phenotype: A single-centre experience

Digestive and Liver Disease

Volumn 46, Issue 6, 2014, Pages 512-517

  Strisciuglio, Caterina ^a   Auricchio, Renata ^a   Martinelli, Massimo ^a   Staiano, Annamaria ^a   Giugliano, Francesca Paola ^a   Andreozzi, Marialuisa ^a   De Rosa, Marina ^a   Giannetti, Eleonora ^a   Gianfrani, Carmela ^a,b   Izzo, Paola ^a   Troncone, Riccardo ^a   Miele, Erasmo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INSTITUTE OF PROTEIN BIOCHEMISTRY   (Italy)

Author keywords

Autophagy; Crohn's disease; Genome wide association studies; Inflammatory bowel diseases

Indexed keywords

ATG16L1 PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; IMMUNOSUPPRESSIVE AGENT; PROTEIN; UNCLASSIFIED DRUG; ADALIMUMAB; AZATHIOPRINE; INFLIXIMAB; METHOTREXATE; ATG16L1 PROTEIN, HUMAN; C REACTIVE PROTEIN; CALGRANULIN; CARRIER PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; IRGM PROTEIN, HUMAN; NOD2 PROTEIN, HUMAN;

ADOLESCENT; ALLELE; ARTICLE; AUTOPHAGY; CHILD; CROHN DISEASE; DISEASE CLASSIFICATION; DISEASE COURSE; FEMALE; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RELAPSE; SINGLE NUCLEOTIDE POLYMORPHISM; CLINICAL FEATURE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENOTYPE; PHENOTYPE; RECURRENT DISEASE; RISK; CHEMISTRY; FECES; GENETICS; HETEROZYGOTE; HOMOZYGOTE; ILEITIS; INFANT; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; STENOSIS, OCCLUSION AND OBSTRUCTION;

ADOLESCENT; AUTOPHAGY; C-REACTIVE PROTEIN; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; CONSTRICTION, PATHOLOGIC; CROHN DISEASE; FECES; FEMALE; GTP-BINDING PROTEINS; HETEROZYGOTE; HOMOZYGOTE; HUMANS; ILEITIS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; NOD2 SIGNALING ADAPTOR PROTEIN; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE; SEVERITY OF ILLNESS INDEX;

EID: 84902550990     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.02.016     Document Type: Article

References (37)

1. Trinh T.T., Rioux J.D. Understanding association and causality in the genetic studies of inflammatory bowel disease. Gastroenterology 2005, 129:2106-2110.
2. Mathew C.G. New links to the pathogenesis of Crohn disease provided by genome-wide association scans. Nature Reviews Genetics 2008, 9:9-14.
3. Hugot J.P., Laurent-Puig P., Gower-Rousseau C., et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 1996, 379:821-823.
4. Ogura Y., Bonen D.K., Inohara N., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001, 411:603-606.
5. Economou M., Trikalinos T.A., Loizou K.T., et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. American Journal of Gastroenterology 2004, 99:2393-2404.
6. Van Limbergen J., Russell R.K., Nimmo E.R., et al. The genetics inflammatory bowel disease. American Journal of Gastroenterology 2007, 102:2820-2831.
7. Klionsky D.J. Crohn's disease, autophagy, and the Paneth cell. New England Journal of Medicine 2009, 360:1785-1786.
8. Hampe J., Franke A., Rosenstiel P., et al. A genome wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nature Genetics 2007, 39:207-211.
9. Weiss B., Shamir R., Bujanover Y., et al. NOD2/CARD15 mutation analysis and genotype-phenotype correlation in Jewish pediatric patients compared with adults with Crohn's disease. Journal of Pediatrics 2004, 145:208-212.
10. De Ridder L., Weersma R.K., Dijkstra G., et al. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflammatory Bowel Diseases 2007, 13:1083-1092.
11. Prescott N.J., Fisher S.A., Franke A., et al. A nonsynonymus SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 2007, 132:1665-1671.
12. Wagner J., Sim W.H., Ellis J.A., et al. Interaction of Crohn's disease susceptibility genes in an Australian paediatric cohort. PLoS ONE 2010, 5:e15376. 10.1371/journal.pone.0015376.
13. IBD Working Group of the European Society for Paediatric Gastroenterology Hepatology and Nutrition. Inflammatory bowel disease in children and adolescents: recommendations for diagnosis - the Porto criteria. Journal of Pediatric Gastroenterology and Nutrition 2005, 41:1-7.
14. Levine A., Griffiths A., Markowitz J., et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflammatory Bowel Diseases 2011, 17:1314-1321.
15. Hyams J.S., Ferry G.D., Mandel F.S., et al. Development and validation of a pediatric Crohn's disease activity index. Journal of Pediatric Gastroenterology and Nutrition 1991, 12:439-447.
16. Hyams J., Crandall W., Kugathasan S., et al. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology 2007, 132:863-873.
17. Biancone L., Michetti P., Travis S., et al. European evidence-based consensus on the management of ulcerative colitis: special situations. Journal of Crohn's and Colitis 2008, 2:63-92.
18. Miller S.A., Dykes D.D., Polesky H.F. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Research 1988, 16:1215.
19. De Rosa M., Scarano M.I., Panarello L., et al. The mutation spectrum of the APC gene in FAP patients from southern Italy: detection of known and four novel mutation. Human Mutation 2003, 21:655-656.
20. Latiano A., Palmieri O., Valvano M.R., et al. Replication of interleukin 23 receptor and autophagy-related 16-like 1 association in adult- and pediatric-onset inflammatory bowel disease in Italy. World Journal of Gastroenterology 2008, 14:4643-4651.
21. Van Limbergen J., Russell R.K., Nimmo E.R., et al. Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe. Inflammatory Bowel Diseases 2008, 14:338-346.
22. Gazouli M., Pachoula I., Panayotou I., et al. NOD2/CARD15, ATG16L1 and IL23R gene polymorphisms and childhood-onset of Crohn's disease. World Journal of Gastroenterology 2010, 16:1753-1758.
23. Lacher M., Schroepf S., Ballauf A., et al. Autophagy ATG16L1 rs2241880 G allele is associated with Crohn's disease in German children. Acta Paediatrica 2009, 98:1835-1840.
24. Fowler E.V., Doecke J., Simms L.A., et al. ATG16L1 T300A shows strong associations with disease subgroups in a large Australian IBD population: further support for significant disease heterogeneity Elizabeth V. American Journal of Gastroenterology 2008, 103:2519-2526.
25. Lewis J.D. The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease. Gastroenterology 2011, 140:1817-1826.
26. Strisciuglio C., Miele E., Wildenberg M.E., et al. T300A variant of autophagy ATG16L1 gene is associated with decreased antigen sampling and processing by dendritic cells in pediatric Crohn's disease. Inflammatory Bowel Diseases 2013, 19:2339-2348.
27. Blumberg R., Cho J., Lewis J., et al. Inflammatory bowel disease: an update on the fundamental biology and clinical management. Gastroenterology 2011, 140:1701-1703.
28. Areola M., Ugolini G., Rivetti S., et al. IL13, NOD2/CARD15, ATG16L1 and PHOX2B polymorphisms in a group of patients with Crohn's disease and correlation with sub-phenotypes. International Journal of Molecular Medicine 2011, 27:469-477.
29. Amre D.K., Mack D.R., Morgan K., et al. Autophagy gene ATG16L1 but no IRGM is associated with Crohn's disease in Canadian children. Inflammatory Bowel Diseases 2009, 15:501-507.
30. Lakatos P.L., Szamosi T., Szilvasi A., et al. ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients. Digestive and Liver Disease 2008, 40:867-873.
31. Xavier R.J., Huett A., Rioux J.D. Autophagy as an important process in gut homeostasis and Crohn's disease pathogenesis. Gut 2008, 57:717-720.
32. Bonen D.K., Cho J.H. The genetics of inflammatory bowel disease. Gastroenterology 2003, 124:521-536.
33. Lesage S., Zouhali H., Cezard J.P., et al. CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. American Journal of Human Genetics 2002, 70:845-857.
34. Ahmad T., Armuzzi A., Bunce M., et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002, 122:854-866.
35. Annese V., Lombardi G., Perri F., et al. Variants of CARD15 are associated with an aggressive clinical course of Crohn's disease - an IG-IBD study. American Journal of Gastroenterology 2005, 100:84-92.
36. Russell R.K., Drummond H.E., Nimmo E.E., et al. Genotype-phenotype analysis in childhood-onset Crohn's disease: NOD2/CARD15 variants consistently predict phenotypic characteristics of severe disease. Inflammatory Bowel Diseases 2005, 11:955-964.
37. Helio T., Halme L., Lappalainen M., et al. CARD15/NOD2 gene variants are associated with familially occurring and complicated forms of Crohn's disease. Gut 2003, 52:558-562.